Patients may not be receiving any other investigational agents with the intention to treat their cancer (imaging trials are acceptable)
Other investigational agents/therapy with the intention to treat the disease under study (observational or imaging trials are acceptable)
Other investigational agents/therapy with the intention to treat the disease under study (observational or imaging trials are acceptable)
Other investigational agents/therapy with the intention to treat the disease under study (observational or imaging trials are acceptable)
Other investigational agents/therapy with the intention to treat the disease under study (observational or imaging trials are acceptable)